Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori

Overview of attention for article published in Respiratory Research, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 16 X posts from 14 X users, with an upper bound of 21,349 followers.

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori. https://t.co/pEPYyOH9ZM https://t.co/ffiVxYgw7l

RT @donsin4: Can we use a blood test or breath test to target chronic #macrolide therapy to prevent #exacerbations in #COPD. Yes, we can. A…

RT @donsin4: Can we use a blood test or breath test to target chronic #macrolide therapy to prevent #exacerbations in #COPD. Yes, we can. A…

RT @donsin4: Can we use a blood test or breath test to target chronic #macrolide therapy to prevent #exacerbations in #COPD. Yes, we can. A…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.